ATRC (AtriCure) Asset Turnover: 0.22 (As of Mar. 2026)


ATRC AtriCure Inc ATRC
76 GF Score
Price $28.26
GF Value $39.73
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is AtriCure Asset Turnover?

AtriCure ATRC -0.63% 76 Asset Turnover is 0.22 as of Mar. 2026. GuruFocus rates ATRC with a GF Score™ of 76/100 and a GF Value™ of $39.73 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. AtriCure's Revenue for the three months ended in Mar. 2026 was $141.2 Mil. AtriCure's Total Assets for the quarter that ended in Mar. 2026 was $649.1 Mil. Therefore, AtriCure's Asset Turnover for the quarter that ended in Mar. 2026 was 0.22.

Asset Turnover is linked to ROE % through Du Pont Formula. AtriCure's annualized ROE % for the quarter that ended in Mar. 2026 was 0.09%. It is also linked to ROA % through Du Pont Formula. AtriCure's annualized ROA % for the quarter that ended in Mar. 2026 was 0.07%.


AtriCure  (NAS:ATRC) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

AtriCure's annulized ROE % for the quarter that ended in Mar. 2026 is

ROE %**(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=0.432/491.814
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(0.432 / 564.996)*(564.996 / 649.0835)*(649.0835/ 491.814)
=Net Margin %*Asset Turnover*Equity Multiplier
=0.08 %*0.8705*1.3198
=ROA %*Equity Multiplier
=0.07 %*1.3198
=0.09 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

AtriCure's annulized ROA % for the quarter that ended in Mar. 2026 is

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=0.432/649.0835
=(Net Income / Revenue)*(Revenue / Total Assets)
=(0.432 / 564.996)*(564.996 / 649.0835)
=Net Margin %*Asset Turnover
=0.08 %*0.8705
=0.07 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


AtriCure Asset Turnover Related Terms


AtriCure Asset Turnover Historical Data

* Premium members only.

The historical data trend for AtriCure's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AtriCure Asset Turnover Chart

AtriCure Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.55 0.67 0.76 0.85

AtriCure Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.23 0.22 0.22 0.22

ATRC vs STAA, NNNN, KMTS: Asset Turnover Comparison

For the Medical Instruments & Supplies subindustry, AtriCure's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AtriCure Asset Turnover vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AtriCure's Asset Turnover distribution charts can be found below:

* The bar in red indicates where AtriCure's Asset Turnover falls into.


ATRC
76GF Score
AtriCure Inc ATRC
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AtriCure Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

AtriCure's Asset Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=534.528/( (609.328+654.179)/ 2 )
=534.528/631.7535
=0.85

AtriCure's Asset Turnover for the quarter that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=141.249/( (654.179+643.988)/ 2 )
=141.249/649.0835
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.22 mean?
AtriCure (ATRC) has a Asset Turnover of 0.22 as of Mar. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on AtriCure and its competitors.
Is AtriCure's Asset Turnover too high?
AtriCure's current Asset Turnover is 0.22. Overall, AtriCure has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AtriCure's Asset Turnover compare to STAA and NNNN?
AtriCure's Asset Turnover of 0.22 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Medical Devices & Instruments company?
A good Asset Turnover depends on the Medical Devices & Instruments industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on AtriCure and its competitors. AtriCure's current Asset Turnover is 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AtriCure stock overvalued right now?
Based on GuruFocus' analysis, AtriCure (ATRC) is currently considered Modestly Undervalued. The stock's GF Value™ is $39.73, compared to a current price of $28.26 — trading 28.9% below its estimated fair value. The current Asset Turnover is 0.22. AtriCure's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For AtriCure (ATRC), the current Asset Turnover is 0.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AtriCure (ATRC) Overvalued in 2026?

Based on GuruFocus' analysis, AtriCure stock appears to be undervalued. The current stock price of $28.26 is trading 28.9% below its estimated GF Value™ of $39.73. GuruFocus considers AtriCure to be Modestly Undervalued.

Key valuation signals for ATRC:

  • Asset Turnover: 0.22
  • GF Value™: $39.73 vs. price of $28.26 (28.9% below fair value)
  • GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the ATRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AtriCure Business Description

Address 7555 Innovation Way, Mason, OH, USA, 45040
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
76GF Score

Get the complete analysis for ATRC

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.26
Price
$39.73
GF Value